Skip to main content
OpenTrials

Clinical trial condition

Meibomian Gland Dysfunction

Explore clinical trials studying Meibomian Gland Dysfunction. Study availability and eligibility vary by location and protocol.

123 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Meibomian Gland Dysfunction trial results

Completed

Evaluation of the LipiFlow System With a New Activator

NCT04500821

Conditions
Eye Diseases, Eyelid Diseases, Meibomian Gland Dysfunction
Locations
  • Empire Eye and Laser Center Bakersfield, California, United States
  • Wolstan & Goldberg Eye Associates Torrance, California, United States
  • Texas Eye Research Center Hurst, Texas, United States
View Trial Details
Completed

Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study

NCT03956225

Conditions
Dry Eye Syndromes, Evaporative Dry Eye Disease, Eye Diseases, +3 more
Locations
  • Alcon Investigator 9083 Long Beach, California, United States
  • Alcon Investigator 9081 Los Angeles, California, United States
  • Alcon Investigator 9084 San Diego, California, United States
  • Alcon Investigator 5127 Panama City, Florida, United States
View all 15 locations
View Trial Details
Completed

A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice

NCT03708367

Conditions
Cataract, Cataracts, Eye Diseases, +4 more
Locations
  • Empire Eye & Laser Center, Inc. Bakersfield, California, United States
  • Eye Doctors of Washington Chevy Chase, Maryland, United States
  • Matossian Eye Associates Pennington, New Jersey, United States
  • JW Eye Associates, P.A. Dallas, Texas, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

NCT03888378

Conditions
Eye Diseases, Eyelid Diseases, MGD-Meibomian Gland Dysfunction, +2 more
Locations
  • Clinical site - 4 Azusa, California, United States
  • Clinical site - 16 Huntington Beach, California, United States
  • Clinical site - 12 Inglewood, California, United States
  • Clinical site - 13 Mission Hills, California, United States
View all 20 locations
View Trial Details
Completed

Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease

NCT02218489

Conditions
Blepharitis, Eye Diseases, Eyelid Diseases, +5 more
Locations
  • UAB School of Optometry Birmingham, Alabama, United States
  • Sall Research Medical Center Artesia, California, United States
  • North Valley Eye Medical Group Mission Hills, California, United States
  • Wolstan & Goldberg Eye Associates Torrance, California, United States
View Trial Details

Related conditions